Fig. 2.
Direct adjusted rates (continuous endocrine therapy use) at year 1 of follow-up were calculated from final multivariable discontinuation Cox model, with 95% confidence interval, including adjustments for stage, age, year of diagnosis, race, ethnicity, and 3-year NCI modified comorbidity index